Compare PERI & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PERI | SOPH |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | Israel | Switzerland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 412.5M | 367.7M |
| IPO Year | 2005 | 2021 |
| Metric | PERI | SOPH |
|---|---|---|
| Price | $8.42 | $4.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $14.75 | $7.00 |
| AVG Volume (30 Days) | ★ 386.2K | 188.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.68 | $18.48 |
| Revenue Next Year | $8.04 | $16.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.00 | $2.58 |
| 52 Week High | $11.44 | $5.70 |
| Indicator | PERI | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 41.52 | 38.78 |
| Support Level | $8.28 | $4.54 |
| Resistance Level | $10.20 | $4.85 |
| Average True Range (ATR) | 0.33 | 0.23 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 25.09 | 20.00 |
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.